Status:
UNKNOWN
A Registration Study on Depression in Patients With Epilepsy
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Epilepsy
Depression
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.
Detailed Description
As the treatment rate for depression in epilepsy is unclear and the discordant voice of choosing antidepressants for most doctors, this prospective observational cohort study was designed to better un...
Eligibility Criteria
Inclusion
- The inclusion criteria were as follows: (1) age 18-75, no gender limited; (2) diagnosis of epilepsy according to the definition by ILAE in 2014; (3) the score of 17-item Hamilton Depression Rating Scale greater than 7; (4) Obtaining informed consent of participants. The exclusion criteria were any of the following: (1) having psychiatric symptoms such as hallucination or delusion; (2) progressive neurological diseases and malignant tumors; (3) severe cognitive dysfunction (the score of MMSE less than 10).
Exclusion
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT03247764
Start Date
February 1 2018
End Date
January 31 2022
Last Update
January 11 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, China, 200040
2
Department of Neurology, Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009
3
Anhui Provincial Hospital
Hefei, China
4
Nanjing Brain Hospital
Nanjing, China